Delivery Order SPE2DB24D2100-SPE2DB25FBERQ
- Not listed
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,076,721 units of the biologic medication CIMZIA (certolizumab pegol) 2x200 mg/mL syringe kits, with a ceiling value of $6,892.75 and a period of performance through April 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,748,554 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $7,061.06 and a period of performance through July 10, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CIMZIA 2X200 MG/ML syringe kits. The contract has a ceiling value of $3,530.53 and a period of performance through June 24, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,269,570 units of the pharmaceutical product Cimzia (certolizumab pegol) 2x200 mg/mL syringe kits. The $46,505.06 firm-fixed-price contract has a completion date of February 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $17,262.66 and a period of performance through April 30, 2025. It is not a set-aside contract, indicating open competition. The contract is for the delivery of 4,568,078,466 units of CIMZIA 2X200 MG/ML syringe kits, a prescription medication used to treat various...
- This is a $7,149.86 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a performance period extending through June 12, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,424,699 units of CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of May 30, 2025 and a ceiling value of $44,844.74. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- This is a $12,145.10 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, with a period of performance extending through May 13, 2025. The award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CIMZIA 2X200 MG/ML syringe kits. The contract has a ceiling value of $7,061.06 and a period of performance through July 10, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,562,280 units of the biologic medication CIMZIA (Certolizumab Pegol) 200 mg/mL syringe kits, with a ceiling value of $51,261.92 and a period of performance through September 25, 2023. The contract is not designated as a set-aside....
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBERQDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,528,590 units of the drug CIMZIA (certolizumab pegol) 2X200 mg/mL syringe kits, with a ceiling value of $7,061.06 and a completion date of June 13, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 6/12/25 |